Menu Search
Equities

Medical System Network Co Ltd

MSYMF:PKL

Medical System Network Co Ltd

Actions
  • Price (USD)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MEDICAL SYSTEM NETWORK Co., Ltd. is mainly engaged in the operation of dispensing pharmacy business. The Company operates in five business segments. The Pharmaceutical Product Network segment involves in ordering system of medicines, development and sale of systems, and support services for securitized receivables. The Dispensing Pharmacy segment operates and manages dispensing pharmacies. The Leasing and Equipment-related Business segment involves in the location development of pharmacies, the rental of buildings for clinics, and the operation of buildings and housing for the elderly. The Food Supply segments provides food service within hospitals and welfare facilities. The Others segment involves in clinical trial support services and visiting nursing services.

  • Revenue in JPY (TTM)117.12bn
  • Net income in JPY1.88bn
  • Incorporated1999
  • Employees3.74k
  • Location
    Medical System Network Co Ltd6F, AKK Bldg.24-3, Kita-Jujo Nishi, Chuo-kuSAPPORO-SHI 060-0010JapanJPN
  • Phone+81 116121069
  • Fax+81 116121068
  • Websitehttps://www.msnw.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		4350:TYO since
announced		Transaction
value
PharmaShift Co LtdDeal completed07 Nov 202307 Nov 2023Deal completed-11.51%--
Data delayed at least 20 minutes, as of Nov 06 2024 06:30 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.